CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

WASHINGTON (AP) -- The Trump administration announced on Tuesday that it would revoke guidance to the nation's hospitals that ...

CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

LOS ANGELES -- For Xavier Becerra, who was the HHS secretary during the Biden administration and now a candidate for ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Nearly 5 million Americans with diabetes would qualify to use a GLP-1 receptor agonist for primary stroke prevention but few ...

The FDA approved treprostinil (Yutrepia) inhalation powder for pulmonary arterial hypertension and pulmonary hypertension ...

"PARP inhibitors have been a mainstay in the treatment of metastatic castration-resistant prostate cancer for patients with ...

As we brace for hotter summers and more erratic weather patterns nationwide, we must see this pollen surge not as an isolated ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...